Penumbra

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Penumbra and other ETFs, options, and stocks.

About PEN

Penumbra, Inc. is a thrombectomy company, which designs, develops, manufactures, and markets innovative medical products. It offers neurovascular thrombectomy and embolization and access technologies, neurosurgical tools, Penumbra LANTERN Delivery Microcatheter, and Penumbra Occlusion Device system. 

CEO
Adam Elsesser
CEOAdam Elsesser
Employees
4,500
Employees4,500
Headquarters
Alameda, California
HeadquartersAlameda, California
Founded
2004
Founded2004
Employees
4,500
Employees4,500

PEN Key Statistics

Market cap
11.80B
Market cap11.80B
Price-Earnings ratio
76.35
Price-Earnings ratio76.35
Dividend yield
Dividend yield
Average volume
595.43K
Average volume595.43K
High today
$316.87
High today$316.87
Low today
$290.00
Low today$290.00
Open price
$316.67
Open price$316.67
Volume
1.36M
Volume1.36M
52 Week high
$325.03
52 Week high$325.03
52 Week low
$221.26
52 Week low$221.26

Stock Snapshot

With a market cap of 11.8B, Penumbra(PEN) trades at $300.97. The stock has a price-to-earnings ratio of 76.35.

On 2026-01-13, Penumbra(PEN) stock moved within a range of $290.00 to $316.87. With shares now at $300.97, the stock is trading +3.8% above its intraday low and -5.0% below the session's peak.

Trading activity shows a volume of 1.36M, compared to an average daily volume of 595.43K.

The stock's 52-week range extends from a low of $221.26 to a high of $325.03.

The stock's 52-week range extends from a low of $221.26 to a high of $325.03.

PEN News

Simply Wall St 2d
Is Penumbra’s MMA Embolization Focus and Insider Selling Altering The Investment Case?

Penumbra recently presented at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, while ongoing SEC filings show continued small share sales by...

Is Penumbra’s MMA Embolization Focus and Insider Selling Altering The Investment Case?
Simply Wall St 3d
Do Penumbra's Earnings Warrant Your Attention?

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story even if these companies are loss-making. Un...

Do Penumbra's Earnings Warrant Your Attention?

Analyst ratings

86%

of 21 ratings
Buy
85.7%
Hold
9.5%
Sell
4.8%

People also own

Based on the portfolios of people who own PEN. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the .